Yungjin Pharm Co Ltd (003520):企業の財務・戦略的SWOT分析

◆英語タイトル:Yungjin Pharm Co Ltd (003520) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15127
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also offers cefaclor cap and dry syr, cefadroxil monohydrate, cefalexin monohydrate, cefamandole inj, cefcapene pivoxil tab and fine gran, cefmetazole inj, cefminox inj, cefotaxime inj, cefatrizine propylene glycolate, and others. Yungjin provides formulation products for various therapeutic areas such as antibiotics, CNS, cardiovascular, endocrine system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, urinary system, vitamin and supplement and cosmetics, among others. The company also offers tonic drinks with pidotimod liquid. It operates through research and development institute, and factory located in Korea. Yungjin is headquartered in Seoul, South Korea.

Yungjin Pharm Co Ltd Key Recent Developments

Jan 07,2019: Yungjin Pharm has obtained the ‘ISO 37001′, the international standard for anti-corruption management system

This comprehensive SWOT profile of Yungjin Pharm Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Yungjin Pharm Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Yungjin Pharm Co Ltd – Key Information
Yungjin Pharm Co Ltd – Overview
Yungjin Pharm Co Ltd – Key Employees
Yungjin Pharm Co Ltd – Key Employee Biographies
Yungjin Pharm Co Ltd – Key Operational Heads
Yungjin Pharm Co Ltd – Major Products and Services
Yungjin Pharm Co Ltd – History
Yungjin Pharm Co Ltd – Company Statement
Yungjin Pharm Co Ltd – Locations And Subsidiaries
Yungjin Pharm Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Yungjin Pharm Co Ltd – Business Description
Yungjin Pharm Co Ltd – Corporate Strategy
Yungjin Pharm Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Yungjin Pharm Co Ltd – Strengths
Yungjin Pharm Co Ltd – Weaknesses
Yungjin Pharm Co Ltd – Opportunities
Yungjin Pharm Co Ltd – Threats
Yungjin Pharm Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Yungjin Pharm Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Yungjin Pharm Co Ltd, Key Information
Yungjin Pharm Co Ltd, Key Ratios
Yungjin Pharm Co Ltd, Share Data
Yungjin Pharm Co Ltd, Major Products and Services
Yungjin Pharm Co Ltd, History
Yungjin Pharm Co Ltd, Key Employees
Yungjin Pharm Co Ltd, Key Employee Biographies
Yungjin Pharm Co Ltd, Key Operational Heads
Yungjin Pharm Co Ltd, Other Locations
Yungjin Pharm Co Ltd, Subsidiaries
Yungjin Pharm Co Ltd, Key Manufacturing facilities
Yungjin Pharm Co Ltd, Key Competitors
Yungjin Pharm Co Ltd, SWOT Analysis
Yungjin Pharm Co Ltd, Ratios based on current share price
Yungjin Pharm Co Ltd, Annual Ratios
Yungjin Pharm Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Yungjin Pharm Co Ltd, Performance Chart
Yungjin Pharm Co Ltd, Ratio Charts

★海外企業調査レポート[Yungjin Pharm Co Ltd (003520):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hotel Grand Central Limited:企業の戦略・SWOT・財務情報
    Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務分析
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mr. Price Group Ltd.:企業の戦略・SWOT・財務情報
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • HC2 Holdings, Inc.:企業のM&A・事業提携・投資動向
    HC2 Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HC2 Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Pilgrim’s Pride Corporation (PPC):企業の財務・戦略的SWOT分析
    Pilgrim's Pride Corporation (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Burlington Stores, Inc.:企業の戦略・SWOT・財務分析
    Burlington Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Burlington Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ulta Salon, Cosmetics & Fragrance Inc:戦略・SWOT・企業財務分析
    Ulta Salon, Cosmetics & Fragrance Inc - Strategy, SWOT and Corporate Finance Report Summary Ulta Salon, Cosmetics & Fragrance Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Kier Group Plc (KIE):電力:M&Aディール及び事業提携情報
    Summary Kier Group plc (Kier) is a construction and property development company specialized in residential and commercial property development, and infrastructure project investment. The company’s services portfolio include construction and civil engineering, support services, property development, …
  • AM Conservation Group Inc:電力:M&Aディール及び事業提携情報
    Summary AM Conservation Group Inc (AM Conservation) a subsidiary of Kohlberg & Company LLC is a clean technology company that manufactures, designs and distributes energy conservation products. The company provides products such as water conservation products, energy efficient products, energy effic …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Danaher Corp (DHR):医療機器:M&Aディール及び事業提携情報
    Summary Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions …
  • Barco NV (BAR):企業の財務・戦略的SWOT分析
    Barco NV (BAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Franklin Resources Inc:企業の戦略・SWOT・財務分析
    Franklin Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Franklin Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Widex AS:企業の戦略的SWOT分析
    Widex AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • CharlestonPharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary CharlestonPharma LLC (CharlestonPharma) is a drug development company that develops anti-nucleolin antibodies for the treatment of cancer. The company uses in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that targets nucleolin located i …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Environics Oy:企業の戦略・SWOT・財務情報
    Environics Oy - Strategy, SWOT and Corporate Finance Report Summary Environics Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bombril SA (BOBR4):企業の財務・戦略的SWOT分析
    Bombril SA (BOBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Mercury Systems, Inc.:企業のM&A・事業提携・投資動向
    Mercury Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercury Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆